Lung cancer as secondary malignance

D. Z. Kocic, D. Dacic, I. Djordjevic (Yugoslavia)

Source: Annual Congress 2002 - Thoracic oncology: rare tumours and metastases
Session: Thoracic oncology: rare tumours and metastases
Session type: Thematic Poster Session
Number: 2942
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Z. Kocic, D. Dacic, I. Djordjevic (Yugoslavia). Lung cancer as secondary malignance. Eur Respir J 2002; 20: Suppl. 38, 2942

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung cancer
Source: Virtual Congress 2020 – Impact in children and in adults with premorbid respiratory disease (acute and long-term)
Year: 2020


Lung cancer
Source: Breathe 2016; 12: 392-399
Year: 2016


Lung cancer
Source: School Course 2014 - Pulmonary Rehabilitation
Year: 2014


Lung cancer as a second primary
Source: Eur Respir J 2007; 30: Suppl. 51, 430s
Year: 2007

Breast metastasis from primary EGFR-mutated lung carcinoma or primary tumor?
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016


Lung cancer patients
Source: Eur Respir Monogr 2021; 90: 165-180
Year: 2021


Evaluation of lung cancer patients with distant organ metastasis
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014

Lung cancer screening
Source: International Congress 2017 – Chinese Programme 2017
Year: 2017

Lung cancer screening
Source: Guideline 2015
Year: 2015

Lung cancer screening
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Prognostic impact of secondary malignancies in non-small cell lung cancer (NSCLC)
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015

Lung cancer immunotherapy
Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance!
Year: 2018